2.A.106.2.2 Ca2+/Mn2+/Mg2+:H+ antiporter, TMEM165 (PT27; TPARL; SLC64A1) of 324 aas and 7 TMSs in a 1 (N-terminal) + 3 + 3 TMS arrangement (Demaegd et al. 2013). It may be both a Ca2+:H+ and a Mn2+:H+ antiporter (Dulary et al. 2016; Stribny et al. 2020), catalyzing uptake of Mn2+ from the cytoplasm into the golgi lumen. TMEM165 has been linked to congenital disorders of glycosylation (CDG) (Foulquier et al. 2012). It may influence glycosylation due to its Mn2+ transport activity that regulates Mn2+ homeostasis in the golgi (Thines et al. 2018). TMEM165 is also required for milk production (Snyder et al. 2019). In humans, both Ca2+ and Mn2+ are required for proper protein glycosylation in cells (Stribny et al. 2020). TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma, and its depletion impairs invasion activity (Lee et al. 2018). The pathogenicity of TMEM165 variants using structural modeling based on AlphaFold 2 predictions has been presented (Legrand et al. 2023). Mutations in the gene encoding TMEM165 are a cause of a new type of congenital disorder of
glycosylation (CDG) (Jankauskas et al. 2024). Comprehensive studies of TMEM165 in different model
systems, including mammals, yeast, and fish uncovered the new realm of
Mn2+ homeostasis regulation. TMEM165 was shown to act as a Ca2+/Mn2+:H+ antiporter in the medial- and trans-Golgi network, pumping the metal
ions into the Golgi lumen and protons outside. Disruption of TMEM165
antiporter activity results in defects in N- and O-glycosylation of
proteins and glycosylation of lipids. Impaired glycosylation of
TMEM165-CDG arises from a lack of Mn2+ within the Golgi. Nevertheless, Mn2+ insufficiency in the Golgi is compensated by the activity of the ATPase
SERCA2. TMEM165 turnover has also been found to be regulated by the Mn2+ cytosolic concentration. Besides causing CDG, the functional involvement of TMEM165 in several other
pathologies including cancer and mental health disorders has been described. This
systematic review summarizes the available information on TMEM165
molecular structure, cellular function, and its roles in health and
disease (Jankauskas et al. 2024). It may catalyze Ca2+ import into lysosomes (Zhang et al. 2025).
|
Accession Number: | Q9HC07 |
Protein Name: | Transmembrane protein 165 |
Length: | 324 |
Molecular Weight: | 34906.00 |
Species: | Homo sapiens (Human) [9606] |
Number of TMSs: | 5 |
Location1 / Topology2 / Orientation3: |
Membrane1 / Multi-pass membrane protein2 |
Substrate |
calcium(2+), manganese cation, proton |
---|
1: MAAAAPGNGR ASAPRLLLLF LVPLLWAPAA VRAGPDEDLS HRNKEPPAPA QQLQPQPVAV
61: QGPEPARVEK IFTPAAPVHT NKEDPATQTN LGFIHAFVAA ISVIIVSELG DKTFFIAAIM
121: AMRYNRLTVL AGAMLALGLM TCLSVLFGYA TTVIPRVYTY YVSTVLFAIF GIRMLREGLK
181: MSPDEGQEEL EEVQAELKKK DEEFQRTKLL NGPGDVETGT SITVPQKKWL HFISPIFVQA
241: LTLTFLAEWG DRSQLTTIVL AAREDPYGVA VGGTVGHCLC TGLAVIGGRM IAQKISVRTV
301: TIIGGIVFLA FAFSALFISP DSGF